✦ LIBER ✦

521 VPM1002 – a recombinant BCG with favourable preclinical toxicity and immunogenicity for potential improvement of BCG immunotherapy for non-muscle invasive bladder cancer

✍ Scribed by Rentsch, C.A.; Wetterauer, C.; Gsponer, J.R.; Püschel, H.; Bachmann, A.; De Blok, W.; Van Der, Wel N.; Behrens, D.; Minhas, A.; Grode, L.; Eisele, B.; Van Rhijn, B.W.G.

Book ID: 122150950
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 201 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)60513-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP39-08 A LISTERIOLYSIN EXPRESSING BCG W

MP39-08 A LISTERIOLYSIN EXPRESSING BCG WITH FAVOURABLE IMMUNOGENICITY AND PRECLINICAL TOXICITY AS A NOVEL TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER

✍ Rentsch, Cyrill; Wetterauer, Christian; Gsponer, Joel; Püschel, Heike; Bachmann, 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 185 KB

Thirty years of BCG immunotherapy for no

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: A success story with room for improvement

✍ Sven Brandau; Henrik Suttmann 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 224 KB

N40 DISCONTINUANCE OF BCG IMMUNOTHERAPY

N40 DISCONTINUANCE OF BCG IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER IS ASSOCIATED WITH LOWER PROGRESSION FREE SURVIVAL

✍ A. Minich; O.G. Sukonko; S.A. Krasny; S.L. Polyakov; A.I. Rolevich; V.Y. Vasilev 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 590 KB

1786 A PROSPECTIVE COMPARATIVE STUDY OF

1786 A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER

✍ Sengiku, Atsushi; Ito, Masaaki; Miyazaki, Yu; Sawazaki, Harutake; Takahashi, Tak 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 53 KB